click below
click below
Normal Size Small Size show me how
Ch. 56 Pharm
Drugs for Women's Menopause and Reproduction
| Question | Answer |
|---|---|
| Menarche | Start of spontaneous menstration |
| Menopause | Permanent stop of menstration |
| Estrogen-Progestin Combination Products | Also known as CHC, conatin synthetic estrogen and progestin |
| Estrogen Component | Stabilizes uterine endometrium and decreases occurance of irregular bleeding |
| Progestin Component | Changes endometrium making it harder to achieve implantation |
| Oral Contraception (COC) | Most commonly used methods of reversible contraception |
| Advantages of COC's | Shorter lighter periods, decrease blood loss, decrease in uterine cramps, easy to use, high effectiveness, safety, prevent ovarian cysts |
| Goal of COC's | Offer best contraceptive protection while producing the lowest amount of side effects |
| Side Effects of increased estrogen activity | Breast changes, painful periods (dysmenorrhea), heavy periods (mennorhagia) |
| Side Effects of decreased estrogen activity | absence of periods (amenorrhea) and spotting |
| Side Effects of increased progestin activity | Depression, fatigue, and decreased libido |
| Side Effects of decreased progestin activity | Breakthrough bleeding and headaches |
| Three types of COC | Monophasic, Biphasic, and Triphasic |
| Monophasic | Fixed estrogen and progestin levels |
| Biphasic | Fixed estrogen levels and levels of progestin vary |
| Triphasic | Lower levels of estrogen and progestin |
| Extended COC Drugs | Loestrin, Yaz |
| Loestrin | Monophasic, Active pill days are extended, shortens the period |
| Yaz | Monophasic, active pill days are extended, less hormonal changes during cycles. |
| Continuous COC | Cause bleeding to occur 4 times a year |
| Continuous COC Drugs | Seasonale, Seasonique |
| Ortho-Evra Transdermal Patch | Inihibits ovulation, thickens cervical mucus |
| Ortho-Evra Advantages | Decreased menstral flow, cramps, acne, body hair and vaginal dryness |
| Progestin Contraception | Do not contain estrogen. For women who cannot take combined contraceptives |
| Four mechanisms of action for progestin COC | Alteration in cervical mucus, interference in endometrial lining, decreased perstalsis, and interference of LH surge |
| Pharmacokinetics of estrogen COC | Rapidly absorbed orally, eliminated via liver, significant first pass method, half-life 6/20 hours, and excretion through bile and urine |
| Pharmacokinetics of progestin COC | Well absorbed orally, bound to plasma proteins, and half life 5/14 hours |
| Severe Adverse Reactions of CHC | Deep venous thrombosis, pulmonary embolism, myocardial infarction, and breast tumors |
| Three stages of Menopause | Perimenopause, Menopause, and Postmenopause |
| Perimenopause | Before cessation has occured, menstration starts to vary, ovarian follicles are depleted resulting in decreased estrogen |
| Symptoms of perimenopause | Hot flashes, vaginal dryness, decreased libido, joint pain, fatigue and insomnia |
| Menopause | Permanant end of menstration caused by cessation of ovarian function. Average age 50 |
| Postmenopause | When body starts adapting to hormonal changes, increased LH levels, ovaries start to secrete androgens |
| Prempro | Oral hormone replacement therapy |
| Prempro actions | Prevent uterin hyperplasia when estrogen is used. For women with intact uterus |
| Menostar | Lowest dose treatment patch used for postmenopausal osteoporosis. |